llm:
  model: "gpt-5-nano-2025-08-07"
  max_requests_per_minute: 250
  max_tokens_per_minute: 100000
  request_url: "https://api.openai.com/v1/chat/completions"
  token_encoding_name: "o200k_base"
  max_in_flight: 250

data:
  input_file: "data/pubmed_talazoparib.jsonl"
  output_file: "data/relations.jsonl"

logging:
  level: "INFO"
  log_file: "logs/pipeline.log"
  relation_log_file: "logs/relation_log.jsonl"
  processed_pmids_log: "logs/processed_pmids.jsonl"
  fetched_queries_log: "logs/fetched_queries.jsonl"
  logging_level: 20


relation_extraction:
  max_attempts: 5
  threshold: 0.55

named_entity_recognition:
  max_attempts: 5

umls:
  api_key: "8a8c8ead-cf26-40e9-986e-08b358bd9ad7"
  api_url: "https://uts-ws.nlm.nih.gov/rest"

pubmed:
  queries:
    - "PARP inhibitor resistance mechanisms"
    - "biomarker predicts response targeted therapy"
    - "drug combination synergy cancer"
    - "driver mutation oncogene cancer"
    - "pathway inhibition targeted therapy"
    - "synthetic lethality PARP BRCA"
    - "FDA approval cancer drug"
    - "gene expression chemotherapy resistance"
    - "tumor suppressor mutation cancer"
    - "drug overcomes resistance combination"
    - "talazoparib resistance homologous recombination repair"
    - "HRR pathway mutation PARP inhibitor resistance"
    - "replication fork protection talazoparib resistance"
    - "DNA damage response talazoparib resistance mechanism"
    - "biomarker talazoparib response predictive"
    - "drug combination talazoparib overcomes resistance"
    - "acquired resistance talazoparib secondary mutation"
    - "gene expression signature talazoparib resistance"
    - "clinical trial talazoparib resistance progression"
    - "alternative DNA repair pathway PARP resistance"